REG3A and cystic fibrosis: In Germany, Cystic Fibrosis (CF) is diagnosed by Newborn Screening (NS) comprising immunoreactive trypsinogen (IRT)/Pancreatitis-Associated Protein (PAP) measurements, followed by targeted genetic testing for the most common CFTR variants (Heinemann et al., 2016).